Global Patent Index - EP 1899304 A1

EP 1899304 A1 20080319 - 5-AMINO-1H-PYRAZOLE-3-CARBOXYLIC ACID DERIVATIVES AS AGONISTS FOR THE G-PROTEIN COUPLED RECEPTOR (GPCR) RUP38 FOR THE TREATMENT OF METABOLIC-RELATED DISORDERS THEREOF

Title (en)

5-AMINO-1H-PYRAZOLE-3-CARBOXYLIC ACID DERIVATIVES AS AGONISTS FOR THE G-PROTEIN COUPLED RECEPTOR (GPCR) RUP38 FOR THE TREATMENT OF METABOLIC-RELATED DISORDERS THEREOF

Title (de)

5-AMINO-1H-PYRAZOL-3-CARBONSÄUREDERIVATE ALS AGONISTEN DES G-PROTEIN-GEKOPPELTEN REZEPTORS (GPCR) RUP38 ZUR BEHANDLUNG VON STOFFWECHSELERKRANKUNGEN DAMIT

Title (fr)

DERIVES D'ACIDE 5-AMINO-1H-PYRAZOLE-3-CARBOXYLIQUE EN TANT QU'AGONISTES DU RECEPTEUR COUPLE AUX PROTEINES G (RCPG) RUP38 POUR TRAITER DES TROUBLES LIES AU METABOLISME

Publication

EP 1899304 A1 20080319 (EN)

Application

EP 06770837 A 20060523

Priority

  • US 2006019730 W 20060523
  • US 68391205 P 20050523

Abstract (en)

[origin: WO2006127595A1] The present invention relates to certain pyrazole carboxylic acid or ester derivatives of Formula (I) and pharmaceutically acceptable salts thereof which exhibit useful pharmacological properties, for example, as agonists for the GPCR referred to herein as RUP38. Also provided by the present invention are pharmaceutical compositions containing compounds of the invention, and methods of using the compounds and compositions of the invention in the treatment of metabolic-related disorders, such as, dyslipidemia, atherosclerosis, coronary heart disease, insulin resistance, type 2 diabetes, Syndrome-X and the like. In addition, the present invention also provides for the use of the compounds of the invention in combination with other active agents such as those belonging to the class of -glucosidase inhibitors, aldose reductase inhibitors, biguanides, HMG-CoA reductase inhibitors, squalene synthesis inhibitors, fibrates, LDL catabolism enhancers, angiotensin converting enzyme (ACE) inhibitors, insulin secretion enhancers and the like.

IPC 8 full level

C07D 231/38 (2006.01); A61K 31/415 (2006.01); A61P 3/00 (2006.01); A61P 3/04 (2006.01); A61P 3/06 (2006.01); A61P 3/10 (2006.01)

CPC (source: EP)

A61P 3/00 (2017.12); A61P 3/04 (2017.12); A61P 3/06 (2017.12); A61P 3/10 (2017.12); C07D 231/38 (2013.01); C07D 405/12 (2013.01); C07D 405/14 (2013.01); C07D 409/12 (2013.01); C07D 409/14 (2013.01)

Citation (search report)

See references of WO 2006127595A1

Designated contracting state (EPC)

AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

Designated extension state (EPC)

AL BA HR MK YU

DOCDB simple family (publication)

WO 2006127595 A1 20061130; EP 1899304 A1 20080319

DOCDB simple family (application)

US 2006019730 W 20060523; EP 06770837 A 20060523